AMAG dips then recovers on Swiss Rienso recall
This article was originally published in Scrip
Executive Summary
AMAG Pharmaceuticals closed down 10.7% on 22 May after the company said one batch of its intravenous iron deficiency anemia (IDA) drug Rienso (ferumoxytol) was recalled in Switzerland following four adverse events related to hypersensitivity reactions, including one death.